CK Life Sciences

CK Life Sciences International (Holdings) Inc. (Chinese: 長江生命科技集團有限公司) (SEHK: 775), or CK Life Sciences, is the subsidiary of Cheung Kong Holdings in Hong Kong. It is engaged in the business of research and development, commercialization, marketing and sale of biotechnology products. The chairman is Mr. Victor Li, the elder son of Mr. Li Ka-shing, the chairman of Cheung Kong Holdings.

It was established in 2000 and listed on the Hong Kong Stock Exchange via Growth Enterprise Market in 2002 (Former stock code: SEHK: 8222). It was transferred to Main Board of the Hong Kong Stock Exchange in 2008.

References

External links

List of life sciences

The life sciences comprise the fields of science that involve the scientific study of living organisms – such as microorganisms, plants, animals, and human beings – as well as related considerations like bioethics. While biology remains the centerpiece of the life sciences, technological advances in molecular biology and biotechnology have led to a burgeoning of specializations and interdisciplinary fields.

Some life sciences focus on a specific type of life. For example, zoology is the study of animals, while botany is the study of plants. Other life sciences focus on aspects common to all or many life forms, such as anatomy and genetics. Yet other fields are interested in technological advances involving living things, such as bio-engineering. Another major, though more specific, branch of life sciences involves understanding the mind – neuroscience.

The life sciences are helpful in improving the quality and standard of life. They have applications in health, agriculture, medicine, and the pharmaceutical and food science industries.

454 Life Sciences

454 Life Sciences is a biotechnology company based in Branford, Connecticut. It is a subsidiary of Roche, and specializes in high-throughput DNA sequencing.

History and major achievements

454 Life Sciences was founded by Jonathan Rothberg originally as 454 Corporation, a subsidiary of CuraGen Corporation. For their method for low-cost gene sequencing, 454 Life Sciences were awarded the Wall Street Journal's Gold Medal for Innovation in the Biotech-Medical category in 2005. The name 454 was the code name by which the project was referred to at CuraGen and the numbers have no special meaning.

In November 2006, Rothberg, Michael Egholm, and colleagues at 454 published a cover article with Svante Pääbo in Nature describing the first million base pairs of the Neanderthal genome, and initiated the Neanderthal Genome Project to complete the sequence of the Neanderthal genome by 2009.

Ownership

In late March 2007, Roche Diagnostics announced an agreement to purchase 454 Life Sciences for US$154.9 million. It will remain a separate business unit. In October 2013, Roche announced that it will shut down 454, and stop supporting the platform by mid-2016.

Life Sciences (journal)

Life Sciences is a weekly peer-reviewed scientific journal covering research on the molecular, cellular, and physiological mechanisms of pharmacotherapy.

Indexed by ISI Life Sciences received an impact factor of 2.702 as reported in the 2014 Journal Citation Reports by Thomson Reuters, ranking it 53rd out of 123 journals in the category Medicine, research & experimental and ranking it 103rd out of 254 journals in the category "Pharmacology & Pharmacy".

The current Editor in Chief is Loren E. Wold

References

External links